Skip to main content
. 2020 Jan 3;2020:4717258. doi: 10.1155/2020/4717258

Figure 8.

Figure 8

Proposed pathway for Eze and its downstream targets. Eze increases levels of phosphorylated AMPK and activates Nrf2, which translocates into the nucleus to increase the transcription of HO-1—a protein that inhibits ROS and inflammation.